{"schema_version":"secwatch.filing_event.v1","accession":"0000896264-26-000030","form_type":"8-K","ticker":"USNA","cik":"0000896264","company_name":"USANA HEALTH SCIENCES INC","filed_at":"2026-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.900829+00:00","generated_at":"2026-05-14T23:43:37.624629+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"USANA Q1 2026 EPS down 16% YoY to $0.41; reaffirms FY guidance","bullets":["Net sales $250M flat YoY; net earnings $7.5M (-20%); diluted EPS $0.41 vs $0.49.","Adjusted diluted EPS $0.61 vs $0.73; adjusted EBITDA $28.4M (-5%).","Core Nutritional active customers 404,000 (-12%); Hiya active subscribers 186,000 (-17%).","Rise Wellness net sales $14M (+741%) from Costco nationwide launch.","Reiterates FY2026 outlook: consolidated net sales $925M–$1.0B; adjusted EPS $1.95–$2.29."],"urls":{"canonical":"https://secwatch.observer/filing/0000896264-26-000030","json":"https://secwatch.observer/filing/0000896264-26-000030.json","markdown":"https://secwatch.observer/filing/0000896264-26-000030.md","text":"https://secwatch.observer/filing/0000896264-26-000030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896264/000089626426000030/0000896264-26-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896264/000089626426000030/usna-20260505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:43:37.624629+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d52176a2d87198a106a68859234149fa1ca93e3e","claim":"USANA HEALTH SCIENCES INC reported first quarter ended April 4, 2026 results: revenue $250 million, net income $7.5 million, EPS $0.41. Guidance reaffirmed.","evidence_excerpt":"(NYSE: USNA) today announced financial results for its fiscal first quarter ended April 4, 2026. Key Financial Results First Quarter 2026 vs. First Quarter 2025 • Net sales of $250 million versus $250 million. • Net earnings of $7.5 million versus $9.4 million. • Diluted EPS of $0.41 as compared with $0.49. • Adjusted diluted EPS (1) of $0.61 as compared with","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/896264/000089626426000030/0000896264-26-000030-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended April 4, 2026"},{"label":"Revenue","value":"$250 million"},{"label":"Net income","value":"$7.5 million"},{"label":"EPS","value":"$0.41"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}